Human Genome Epidemiology Literature Finder
Records 1 - 11 (of 11 Records) |
Query Trace: Ovarian Neoplasms and EPCAM[original query] |
---|
Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes. Journal of experimental & clinical cancer research : CR 2014 33 74. Mancini-DiNardo Debora, Judkins Thaddeus, Woolstenhulme Nick, Burton Collin, Schoenberger Jeremy, Ryder Matthew, Murray Adam, Gutin Natalia, Theisen Aaron, Holladay Jayson, Craft Jonathan, Arnell Christopher, Moyes Kelsey, Roa Benjam |
Single nucleotide polymorphisms of the EpCAM-coding gene TACSTD1 in patients with ovarian cancer and their potential translational aspects. Archives of gynecology and obstetrics 2015 Jun . Heubner Martin, Wimberger Pauline, Kasimir-Bauer Sabine, Singer Bernhard B, Ruf Peter, Kimmig Rainer, Siffert Winfri |
A Comparative Analysis of Breast and Ovarian Cancer-related Gene Mutations in Canadian and Saudi Arabian Patients with Breast Cancer. Anticancer research 2015 May 35 (5): 2601-10. Amemiya Yutaka, Bacopulos Stephanie, Al-Shawarby Mohamed, Al-Tamimi Dalal, Naser Walid, Ahmed Ayesha, Khalifa Mahmoud, Slodkowska Elzbieta, Seth Ar |
Prioritizing Variants in Complete Hereditary Breast and Ovarian Cancer Genes in Patients Lacking Known BRCA Mutations. Human mutation 2016 Feb . Caminsky Natasha G, Mucaki Eliseos J, Perri Ami M, Lu Ruipeng, Knoll Joan H M, Rogan Peter |
Analysis of Circulating Tumor Cells in Ovarian Cancer and Their Clinical Value as a Biomarker. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 8 48 (5): 1983-1994. Zhang Xuehui, Li Hui, Yu Xiuyan, Li Shanxin, Lei Zhen, Li Chang, Zhang Qun, Han Qing, Li Yuan, Zhang Kun, Wang Yuxiang, Liu Congrong, Mao Yiqing, Wang Xi, Irwin David M, Guo Hongyan, Niu Gang, Tan Huanr |
High frequency of pathogenic non-founder germline mutations in BRCA1 and BRCA2 in families with breast and ovarian cancer in a founder population. Hereditary cancer in clinical practice 2018 16 12. Maksimenko J, Irmejs A, Trofimovi?s G, B?rzi?a D, Skuja E, Purkalne G, Miklaševi?s E, Gardovskis |
New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability. Genetic testing and molecular biomarkers 2022 1 26 (1): 17-25. Sahin Ibrahim, Saat Hani |
No Evidence of Increased Risk of Breast Cancer in Women With Lynch Syndrome Identified by Multigene Panel Testing. JCO precision oncology 2022 1 4 51-60. Stoll Jessica, Rosenthal Eric, Cummings Shelly, Willmott Jamie, Bernhisel Ryan, Kupfer Sonia |
Retrospective Cohort Study on the Limitations of Direct-to-Consumer Genetic Screening in Hereditary Breast and Ovarian Cancer. JCO precision oncology 2023 8 7 e2200695. Neelam V Desai, Elizabeth D Barrows, Sarah M Nielsen, Kathryn E Hatchell, Michael J Anderson, Eden V Haverfield, Blanca Herrera, Edward D Esplin, Anneke Lucassen, Nadine M Tung, Claudine Isaa |
Uncommon variants detected via hereditary cancer panel and suggestions for genetic counseling. Mutation research 2023 7 827 111831. Zeynep Özdemir, Ezgi Çevik, Ömür Berna Çakmak Öksüzo?lu, Mutlu Do?an, Öztürk Ate?, Ece Esin, ?rem Bilgetekin, Umut Demirci, Ça?lar Köseo?lu, Alper Topal, Nuri Karadurmu?, Haktan Ba??? Erdem, Taha Bah |
Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. Breast cancer research and treatment 2023 3 . Bychkovsky Brittany L, Lo Min-Tzu, Yussuf Amal, Horton Carrie, Hemyari Parichehr, LaDuca Holly, Garber Judy E, Scheib Rochelle, Rana Huma |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 29, 2023
- Content source: